Literature DB >> 3053164

Expression of functional human EGF receptor on murine bone marrow cells.

T von Rüden1, E F Wagner.   

Abstract

The human epidermal growth factor-receptor (EGF-R) was introduced into primary mouse bone marrow cells (BMC), utilizing retrovirus mediated gene transfer. Cultivation of infected BMC in the presence of interleukin-3 (IL-3) led to the outgrowth of IL-3 dependent myeloid cells, which efficiently expressed functional EGF-R, exhibiting its two characteristic affinity states. EGF acts on these cells synergistically with IL-3 in stimulating DNA synthesis and cell proliferation even under IL-3 saturation conditions. However, EGF was not sufficient to replace the requirement for IL-3. In contrast, EGF was able to maintain proliferation of a factor-dependent hemopoietic cell line (FDC-P1) infected with the EGF-R retrovirus in the absence of IL-3, but these cells did not respond to EGF in the presence of IL-3. No influence of EGF on IL-3 induced mast cell differentiation of BMC expressing the EGF-R could be observed by histological criteria. These data show that the expression of EGF-R alone is not sufficient to induce or maintain cell proliferation in IL-3 dependent bone marrow derived cells, although it can do so in established hemopoietic cell lines.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3053164      PMCID: PMC457065          DOI: 10.1002/j.1460-2075.1988.tb03129.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  46 in total

1.  A universal retroviral vector for efficient constitutive expression of exogenous genes.

Authors:  C A Boulter; E F Wagner
Journal:  Nucleic Acids Res       Date:  1987-09-11       Impact factor: 16.971

2.  The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity.

Authors:  T Akiyama; C Sudo; H Ogawara; K Toyoshima; T Yamamoto
Journal:  Science       Date:  1986-06-27       Impact factor: 47.728

3.  Point mutation at the ATP binding site of EGF receptor abolishes protein-tyrosine kinase activity and alters cellular routing.

Authors:  A M Honegger; T J Dull; S Felder; E Van Obberghen; F Bellot; D Szapary; A Schmidt; A Ullrich; J Schlessinger
Journal:  Cell       Date:  1987-10-23       Impact factor: 41.582

4.  Resolution of high and low affinity epidermal growth factor receptors. Inhibition of high affinity component by low temperature, cycloheximide, and phorbol esters.

Authors:  A C King; P Cuatrecasas
Journal:  J Biol Chem       Date:  1982-03-25       Impact factor: 5.157

Review 5.  Role of the v-erbA and v-erbB oncogenes of avian erythroblastosis virus in erythroid cell transformation.

Authors:  T Graf; H Beug
Journal:  Cell       Date:  1983-08       Impact factor: 41.582

6.  Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin.

Authors:  T A Libermann; H R Nusbaum; N Razon; R Kris; I Lax; H Soreq; N Whittle; M D Waterfield; A Ullrich; J Schlessinger
Journal:  Nature       Date:  1985 Jan 10-18       Impact factor: 49.962

7.  Constitutive production of a unique lymphokine (IL 3) by the WEHI-3 cell line.

Authors:  J C Lee; A J Hapel; J N Ihle
Journal:  J Immunol       Date:  1982-06       Impact factor: 5.422

8.  Autophosphorylation sites on the epidermal growth factor receptor.

Authors:  J Downward; P Parker; M D Waterfield
Journal:  Nature       Date:  1984 Oct 4-10       Impact factor: 49.962

9.  Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors.

Authors:  H Karasuyama; F Melchers
Journal:  Eur J Immunol       Date:  1988-01       Impact factor: 5.532

10.  Growth of factor-dependent hemopoietic precursor cell lines.

Authors:  T M Dexter; J Garland; D Scott; E Scolnick; D Metcalf
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

View more
  17 in total

1.  Predominant role of alpha 4-integrins for distinct steps of lymphoma metastasis.

Authors:  U Gosslar; P Jonas; A Luz; A Lifka; D Naor; A Hamann; B Holzmann
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

2.  Expression of epidermal-growth-factor receptor in the K562 cell line by transfection. Altered receptor biochemistry.

Authors:  H Allen; J Hsuan; S Clark; R Maziarz; M D Waterfield; R A Flavell; J Haley
Journal:  Biochem J       Date:  1990-11-01       Impact factor: 3.857

3.  Induction of macrophage colony-stimulating factor-dependent growth and differentiation after introduction of the murine c-fms gene into FDC-P1 cells.

Authors:  L R Rohrschneider; D Metcalf
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

4.  Coexpression of the platelet-derived growth factor (PDGF) B chain and the PDGF beta receptor in isolated pancreatic islet cells stimulates DNA synthesis.

Authors:  M Welsh; L Claesson-Welsh; A Hallberg; N Welsh; C Betsholtz; P Arkhammar; T Nilsson; C H Heldin; P O Berggren
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

5.  Macrophage-colony-stimulating factor (CSF-1) induces proliferation, chemotaxis, and reversible monocytic differentiation in myeloid progenitor cells transfected with the human c-fms/CSF-1 receptor cDNA.

Authors:  J H Pierce; E Di Marco; G W Cox; D Lombardi; M Ruggiero; L Varesio; L M Wang; G G Choudhury; A Y Sakaguchi; P P Di Fiore
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

6.  Mitogenic signalling and substrate specificity of the Flk2/Flt3 receptor tyrosine kinase in fibroblasts and interleukin 3-dependent hematopoietic cells.

Authors:  M Dosil; S Wang; I R Lemischka
Journal:  Mol Cell Biol       Date:  1993-10       Impact factor: 4.272

7.  Anti-oncogenic activity of signalling-defective epidermal growth factor receptor mutants.

Authors:  N Redemann; B Holzmann; T von Rüden; E F Wagner; J Schlessinger; A Ullrich
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

8.  A dual immunocytochemical assay for oestrogen and epidermal growth factor receptors in tumour cell lines.

Authors:  A K Sharma; K Horgan; R A McClelland; A G Douglas-Jones; T Van Agthoven; L C Dorssers; R I Nicholson
Journal:  Histochem J       Date:  1994-04

9.  Differential expression of estrogen, progesterone, and epidermal growth factor receptors in normal, benign, and malignant human breast tissues using dual staining immunohistochemistry.

Authors:  T van Agthoven; M Timmermans; J A Foekens; L C Dorssers; S C Henzen-Logmans
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

10.  A mutation in the epidermal growth factor receptor in waved-2 mice has a profound effect on receptor biochemistry that results in impaired lactation.

Authors:  K J Fowler; F Walker; W Alexander; M L Hibbs; E C Nice; R M Bohmer; G B Mann; C Thumwood; R Maglitto; J A Danks
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.